Development and Validation of a Clostridium difficile Infection Risk Prediction Model

被引:80
作者
Dubberke, Erik R. [1 ]
Yan, Yan [1 ]
Reske, Kimberly A. [1 ]
Butler, Anne M. [1 ]
Doherty, Joshua [2 ]
Pham, Victor [2 ]
Fraser, Victoria J. [1 ]
机构
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Barnes Jewish Hosp, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
STEM-CELL TRANSPLANTATION; DISEASE; DIARRHEA; MORTALITY; OUTBREAK; QUEBEC; TRANSMISSION; INPATIENTS; RECIPIENTS; SEVERITY;
D O I
10.1086/658944
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVE. To develop and validate a risk prediction model that could identify patients at high risk for Clostridium difficile infection (CDI) before they develop disease. DESIGN AND SETTING. Retrospective cohort study in a tertiary care medical center. PATIENTS. Patients admitted to the hospital for at least 48 hours during the calendar year 2003. METHODS. Data were collected electronically from the hospital's Medical Informatics database and analyzed with logistic regression to determine variables that best predicted patients' risk for development of CDI. Model discrimination and calibration were calculated. The model was bootstrapped 500 times to validate the predictive accuracy. A receiver operating characteristic curve was calculated to evaluate potential risk cutoffs. RESULTS. A total of 35,350 admitted patients, including 329 with CDI, were studied. Variables in the risk prediction model were age, CDI pressure, times admitted to hospital in the previous 60 days, modified Acute Physiology Score, days of treatment with high-risk antibiotics, whether albumin level was low, admission to an intensive care unit, and receipt of laxatives, gastric acid suppressors, or antimotility drugs. The calibration and discrimination of the model were very good to excellent (C index, 0.88; Brier score, 0.009). CONCLUSIONS. The CDI risk prediction model performed well. Further study is needed to determine whether it could be used in a clinical setting to prevent CDI-associated outcomes and reduce costs. Infect Control Hosp Epidemiol 2011;32(4):360-366
引用
收藏
页码:360 / 366
页数:7
相关论文
共 38 条
[1]  
[Anonymous], 1993, An introduction to the bootstrap
[2]   Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantation [J].
Bilgrami, S ;
Feingold, JM ;
Dorsky, D ;
Edwards, RL ;
Bona, RD ;
Khan, AM ;
Rodriguez-Pinero, F ;
Clive, J ;
Tutschka, PJ .
BONE MARROW TRANSPLANTATION, 1999, 23 (10) :1039-1042
[3]   Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality [J].
Chakrabarti, S ;
Lees, A ;
Jones, SG ;
Milligan, DW .
BONE MARROW TRANSPLANTATION, 2000, 26 (08) :871-876
[4]   Statistical evaluation of prognostic versus diagnostic models: Beyond the ROC curve [J].
Cook, Nancy R. .
CLINICAL CHEMISTRY, 2008, 54 (01) :17-23
[5]  
D'Agostino R.B., 1997, Proceedings of the Section on Biometrics, P253
[6]   DEVELOPMENT OF HEART RISK APPRAISAL FUNCTIONS IN THE PRESENCE OF MULTIPLE INDICATORS - THE FRAMINGHAM-STUDY NURSING-HOME INSTITUTIONALIZATION MODEL [J].
DAGOSTINO, RB ;
BELANGER, AJ ;
MARKSON, EW ;
KELLYHAYES, M ;
WOLF, PA .
STATISTICS IN MEDICINE, 1995, 14 (16) :1757-1770
[7]   Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease [J].
Dial, S ;
Delaney, JAC ;
Barkun, AN ;
Suissa, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (23) :2989-2995
[8]   Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors:: cohort and case-control studies [J].
Dial, S ;
Alrasadi, K ;
Manoukian, C ;
Huang, A ;
Menzies, D .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 171 (01) :33-38
[9]   Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy [J].
Dial, Sandra ;
Delaney, J. A. Chris ;
Schneider, Verena ;
Suissa, Samy .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 175 (07) :745-748
[10]   Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients [J].
Dubberke, Erik R. ;
Butler, Anne M. ;
Reske, Kimberly A. ;
Agniel, Denis ;
Olsen, Margaret A. ;
D'Angelo, Gina ;
McDonald, L. Clifford ;
Fraser, Victoria J. .
EMERGING INFECTIOUS DISEASES, 2008, 14 (07) :1031-1038